pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Genzyme Corp

updated 2mo ago

Genzyme was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme had a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products were also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products on the market.

community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval38 co-mentions · 19 sources
  • drugvandetanib38 co-mentions · 19 sources
  • drugCAPRELSA38 co-mentions · 19 sources
  • tagSmall Molecule19 co-mentions · 19 sources
pipeline
14
marketed
12
phase 3
0
catalysts ytd
2
approvals ytd
2
recalls ytd
0

Pipeline(14)

view full pipeline →
pipeline depth14 products
Marketed: 12Unknown: 2
12Marketed2Unknown
Marketed
Lemtrada
Relapsing Remitting Multiple Sclerosis (RRMS)
Marketed
Lumizyme
Pompe Disease
Marketed
agalsidase beta
Fabry Disease
Marketed
alemtuzumab
B-Cell Chronic Lymphocytic Leukemia
Marketed
anti-thymocyte globulin (rabbit)
Kidney Transplant Rejection
Marketed
caplacizumab
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)
Marketed
fitusiran
Hemophilia A (Factor VIII Deficiency)
Marketed
imiglucerase
Gaucher Disease Type III
Marketed
laronidase
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Marketed
olipudase alfa
Niemann-Pick Disease Type B (Acid Sphingomyelinase Defici…
Marketed
thyrotropin alfa
Thyroid Gland Disorders
Marketed
vandetanib
Medullary Thyroid Cancer

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Genzyme Corp jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Oncology2Immunology1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?